GC Green Cross, Hanmi Pharmaceutical License Fabry Disease Drug Candidate to BioMarin in Deal Worth Up to 634 Billion Won - 헬스조선

Health By The Chosun Ilbo • October 31, 2026, 2:56 AM UTC
⏱ 1 min read 👁 2 views
Direct Source Verification: This story is aggregated from The Chosun Ilbo (chosun.com). Full reporting rights and copyright belong to the primary publisher.
Read on The Chosun Ilbo ↗
GC Green Cross, Hanmi Pharmaceutical License Fabry Disease Drug Candidate to BioMarin in Deal Worth Up to 634 Billion Won - 헬스조선
GC Green Cross, Hanmi Pharmaceutical License Fabry Disease Drug Candidate to BioMarin in Deal Worth Up to 634 Billion Won  헬스조선
GC Green Cross, Hanmi Pharmaceutical License Fabry Disease Drug Candidate to BioMarin in Deal Worth Up to 634 Billion Won  헬스조선
Original Source
https://health.chosun.com/english/site/data/html_dir/2026/10/30/2026103002831.html
Visit The Chosun Ilbo ↗
SHARE STORY:
𝕏 f in

Related Coverage in Health